Development of Viral Vectors for Use in Cardiovascular Gene Therapy

Cardiovascular disease represents the most common cause of mortality in the developed world but, despite two decades of promising pre-clinical research and numerous clinical trials, cardiovascular gene transfer has so far failed to demonstrate convincing benefits in the clinical setting. In this rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Paul D., Ranjzad, Parisa, Kakar, Salik J., Kingston, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185614/
https://www.ncbi.nlm.nih.gov/pubmed/21994642
http://dx.doi.org/10.3390/v2020334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185614/
https://www.ncbi.nlm.nih.gov/pubmed/21994642
http://dx.doi.org/10.3390/v2020334

Ejemplares similares